Divalproex Sodium (Page 13 of 13)

Divalproex NA 125 MG DR TAB

Label ImageLabel Image
DIVALPROEX SODIUM divalproex sodium tablet, delayed release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68151-1164(NDC:62756-796)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DIVALPROEX SODIUM (VALPROIC ACID) VALPROIC ACID 125 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
STARCH, CORN
POVIDONE, UNSPECIFIED
HYPROMELLOSE, UNSPECIFIED
TITANIUM DIOXIDE
TRIACETIN
METHACRYLIC ACID — ETHYL ACRYLATE COPOLYMER (1:1) TYPE A
TRIETHYL CITRATE
SODIUM BICARBONATE
SODIUM LAURYL SULFATE
FD&C RED NO. 40
FD&C BLUE NO. 2
SHELLAC
FERROSOFERRIC OXIDE
BUTYL ALCOHOL
PROPYLENE GLYCOL
AMMONIA
TALC
Product Characteristics
Color PINK Score no score
Shape OVAL Size 12mm
Flavor Imprint Code 796
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68151-1164-8 1 TABLET, DELAYED RELEASE in 1 PACKAGE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA078597 07/29/2008
Labeler — Carilion Materials Management (079239644)
Establishment
Name Address ID/FEI Operations
Carilion Materials Management 079239644 REPACK (68151-1164)

Revised: 07/2017 Carilion Materials Management

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.